IMG Appoints Executive Vice President

Indianapolis, IN May 30, 2013 – International Medical Group®, Inc. (IMG®), an Indianapolis-based insurance group, today announced that Todd Hancock joined the company as executive vice president, joining the experienced management team led by R. Brian Barwick, president and CEO. The appointment of Mr. Hancock, a seasoned insurance executive with more than 20 years of industry experience, signals a renewed focus on growth and innovation for the reputable global company. Mr. Hancock will be responsible for oversight of the international insurance operations at IMG. He will also work closely with senior management on business development and strategic opportunities for IMG’s family of companies.
“We are pleased to welcome Todd to our dynamic team,” said Mr. Barwick. “His proven track record within the insurance industry, his tactical thinking, and his results-oriented approach will play an essential role in extending IMG’s international reputation for excellence, innovation, quality and service. Todd brings the vision and skills we were looking for in an executive vice president.”
Before his appointment, Mr. Hancock was executive vice president and chief operating officer of Worldwide Expatriate Advisors, an international benefits managing general underwriter. He was responsible for operational integrity including client service systems, policy and broker administration, and claims; sales, marketing and strategic objective setting; oversight of underwriting functions; and oversight of product design and implementation. His specialized experience also includes well-documented work for AmWINS Group, International Health Insurance danmark a/s, UnitedHealth International and Sg2.
“I look forward to working with IMG’s dedicated employees and helping to lead the team through its next phase of development,” said Mr. Hancock. “IMG will continue to focus on its customers, strengthen its core service offerings and expand its global presence.”

IMG and Sister Cities Provide Insurance Solutions to International Travelers

Indianapolis, IN May 21, 2013 – Sister Cities International to Offer IMG International Insurance Products to its Member
International Medical Group®, Inc. (IMG®), a worldwide leader in designing, distributing and administering global health care benefits, today announced its international medical insurance products will be available to members of Sister Cities International effective July 1, 2013. Members will be able to view and purchase a variety of IMG products at www.sister-cities.org. The new relationship is designed to enhance the services offered to Sister Cities International members.
“We are very pleased that Sister Cities International will be offering our products,” said R. Brian Barwick, president and CEO of IMG. “The relationship brings together two best-in-class organizations committed to the well-being and safety of its customers and members. With our premier products and experienced staff, we provide service to our customers wherever they are in the world. Sister Cities International members will now be able to access the international resources and care they need to help their communities continue completing world-class exchanges.”
IMG’s international medical insurance products provide short and long-term coverage for individuals, groups and families traveling, living and working abroad. Each product provides international benefits not found on standard domestic health plans. In addition to competitive premiums, IMG customers have access to multiple international service and assistance centers, multilingual customer service professionals, and claim administrators who process claims from all over the world handling most languages and currencies. They also have 24-hour access to coordinators of emergency medical services and treatment. Additionally, when seeking treatment outside the U.S., customers can access more than 17,000 physicians and facilities through IMG’s proprietary International Provider AccessSM (IPA) database. By offering these specialty products and services, Sister Cities International feels it can bring a complete international insurance solution to its members.
“Sister Cities International is excited to be working alongside International Medical Group,” said Mary Kane, president and CEO of Sister Cities International. “Our members are sure to benefit from IMG’s proven international insurance products and stellar services.”
The relationship was made possible with the help of Donald S. Hardy of Quantum Benefits. Hardy has over 50 years of insurance experience and has been contracted to sell IMG products since 2005. He added, “I am happy to bring these two great organizations together, and I am pleased that the members of Sister Cities International will have access to the quality international insurance they demand.”

Sparta Systems Launches New Business Intelligence Solution, TrackWise Analytics

Helping to Redefine the Benchmark for Enterprise Quality Management Solutions
Hamilton, NJ May 20, 2013 – Sparta Systems, Inc., an industry pioneer and leader in enterprise quality management solutions, today announced the availability of TrackWise Analytics, an enterprise business intelligence (BI) solution that helps redefine the benchmark for quality systems. The solution introduces real-time analytics and ad hoc reporting capabilities to the core quality management functionality of Sparta’s flagship product, TrackWise. TrackWise Analytics is released as part of TrackWise 8.5, the latest version of the Company’s market leading enterprise quality management software (EQMS), which also touts advancements in search, querying and web services integration.
In today’s demanding market, businesses must be able to leverage quality system data to raise awareness of quality among executive management, improve operational visibility and empower faster and more informed decisions. The advanced, real-time data analysis capabilities of TrackWise Analytics enable organizations to turn quality data into insight and action. As a result, they are able to quickly identify emerging trends and implement proactive quality management strategies that address the cost of poor quality.
The new TrackWise Analytics solution empowers users with easy to use drag-and-drop reporting and charting capabilities which deliver real-time intelligence and reduced dependence on technical staff for report creation. Fully embedded in TrackWise, TrackWise Analytics eliminates the need for integration and data migration, lowering a company’s total cost of ownership.
“Our team was given the opportunity to beta test TrackWise Analytics and we were extremely impressed with the solution’s functionality. The technology’s ease of use and key features made it possible for us to identify and respond to quality trends more quickly,” said Robert Davenport, Director of Quality Operations at Par Pharmaceutical Companies, Inc. “Our TrackWise users were able to easily analyze business data, and create tailored reports to meet various organizational needs. This resulted in a quicker generation of routine quality metrics, reduced data analysis times for investigations and quality decisions, and enhanced management visibility of quality trends.”
TrackWise Analytics delivers:
Rapid implementation due to out-of-the-box integration with TrackWise data
Improved executive visibility and transparency within the enterprise quality system
Quality management workforce empowered with real-time analysis and reporting
Reduced dependency on technical/IT staff for report creation and updates
Lower total cost of ownership relative to alternative commercial business intelligence and custom developed solutions
“By listening to our customers’ quality business intelligence needs and leveraging our own deep quality domain expertise, we have delivered an industry leading product that delivers immediate business value,” said Eileen Martinson, CEO, Sparta Systems. “We believe TrackWise 8.5 will be the benchmark against which other EQMS will be evaluated.”
The TrackWise Analytics business intelligence solution is a new product offering available with the TrackWise 8.5 release. For more information, please visit http://www.spartasystems.com/trackwise/trackwise-analytics.

Precyse Offers Solutions to Combat Hospital and Physician Reimbursement Cuts

Hospitals facing onslaught of challenges including recent 2 percent Medicare sequestration
Wayne, PA and Alpharetta, GA May 14, 2013 — As hospitals and healthcare providers begin to face a vast array of reimbursement challenges in 2013, including the 2 percent Medicare reimbursement cuts that went into effect on April 1, 2013, they are looking to Precyse, a leader in Health Information Management (HIM) technology and services, for help. With its expert staffs and customized technology solutions, Precyse is well positioned to help many facilities minimize some of the challenges they are facing.
Most recently, budget sequestration has triggered about $1 trillion in across-the-board cuts to the federal budget, including this 2 percent reduction to Medicare reimbursement rates. The cut applies to payments made for services provided by physicians and hospitals, as well as monthly payments to Medicare private insurers and Part D prescription drug plans.
“Precyse is uniquely positioned to help healthcare facilities quickly affect their unbilled accounts receivable (A/R) and accelerate cash flows while reducing their HIM cost footprint,” explained Precyse President Chris Powell. “Our high quality standards and proven ability to augment and enhance HIM departments by delivering measurable results at reduced costs can empower healthcare providers to take on this latest challenge.”
Precyse’s HIM Strategic Sourcing™, an innovative solution combining technology and services, can help hospital or physician practice HIM departments optimize their effectiveness and advance their capabilities and functions to successfully operate under a more challenging reimbursement environment. Most recently, in just 4 months, Precyse was able to help Naples Community Healthcare System (NCHS), a 672-bed system located in Naples, FL, decrease its inpatient weekly DNFB (Discharged Not Final Billed—unbilled AR) from more than $16 million to $5 million, and its outpatient DNFB from more than $14 million to under $2 million. Also, outpatient accounts receivable days went from 7 days to 2, and average inpatient accounts receivable days went from 10 days to under 2.
In addition to Precyse’s HIM Strategic Sourcing™, Precyse’s clinical documentation improvement (CDI) solutions are demonstrating quick financial returns on investment in only a matter of months. “By implementing a full phase CDI program, our clients are experiencing cash returns of more than $800,000 in only 8 months,” said Mark Hendricks, MBA, RHIA, commercial general manager and vice president for precyseCode™, precyseCDI™ and CDI services. These clients range from a 242-bed facility in New Jersey saving more than $450,000 in 4 months to a Mid-Atlantic health system with 477 beds saving more than $800,000 in less than 8 months.
“It is estimated that facilities can realize $5,000 of incremental annual revenue per staffed bed using our CDI program,” continued Hendricks. “Our clients are improving workflow and productivity while optimizing DRG coding accuracy, cash flow and revenues. In addition, our CDI clients are using their CDI programs to assess quality standards, patient safety goals and compliance. We are also seeing our clients enhancing their ability to identify and resolve problems and to differentiate payment based on performance.”
Precyse’s HIM Strategic Sourcing and CDI services are comprehensive and far reaching, providing HIM departments with the leadership and collaborative spirit needed to drive the change that is necessary to improve results. With Precyse as a partner, healthcare facilities can achieve operational excellence and superior financial performance, positioning them for future success, even in this very challenging reimbursement environment.

OsoBio Appoints David M. Lee Vice President of Quality

Albuquerque, NM May 1, 2013 – OsoBio has named David M. Lee vice president of quality.
Lee is responsible for overseeing all quality-related functions to ensure the company’s continued compliance with Current Good Manufacturing Practices (cGMP), including quality systems, quality control and manufacturing quality assurance.
Lee brings to his role more than 20 years of professional experience managing quality operations and API and sterile manufacturing.
Prior to joining OsoBio in June 2012, Lee served as director of validation and quality at Amgen Inc., where, among other responsibilities, he managed all validation activities for a $1.2-billion site expansion. During his time at Amgen, he also managed production operations for two of the company’s signature chemotherapy drugs, NEUPOGEN® and Neulasta.®
“David’s knowledge and expertise in quality operations will support OsoBio’s ongoing ability to deliver exceptional sterile pharmaceutical manufacturing products and service,” said Milton Boyer, president of OsoBio. “David has already proven to be a great asset to the OsoBio team and the clients we serve.”
Lee holds a master’s degree in biology from California State University, Northridge, and a bachelor’s degree in biology from the University of California, Riverside. He is a member of the Parenteral Drug Association.